Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Rulemaking Clinical Registrant topic
No spam. Unsubscribe anytime.
NJ Cannabis Regulatory Commission adopts clinical-registrant rules, approves medical activity reports
Summary
The New Jersey Cannabis Regulatory Commission voted to adopt rules creating a clinical-registrant permit for ATCs conducting clinical research and approved two medical‑activity reports for 2020–2021, moving both to filing and transmittal to the governor and legislature.
The New Jersey Cannabis Regulatory Commission on July 18 voted to adopt a notice of adoption for new clinical-registrant rules, establishing a permit pathway for certain alternative treatment centers (ATCs) to conduct clinical research in partnership with a regional academic medical center.
The adoption, moved and seconded during the meeting, follows a rule proposal published in the New Jersey Register on Aug. 7, 2023, and a 60‑day public comment period that closed Oct. 6, 2023. Chief counsel Dave Tuason told the commission staff is completing responses to comments and preparing a formal notice of adoption for filing with the Office of Administrative Law.
Why it matters: the new permit type creates a regulated avenue for medical research tied to academic institutions and aligns clinical-registrant applications with the personal‑use application process. Commissioner Nash emphasized research and ethics in her remarks: “I am really interested to learn what research comes out of the partnership between these clinical registrants and academic medical centers,” and she noted the proposed rules include language that “prohibits animal testing in our nonclinical research.”
The commission also considered two statutorily required reports summarizing regulatory and operational medical cannabis activities for 2020 and 2021. Director Riggs said the reports contain anonymous, aggregate data and are intended for transmittal to the governor and the legislature if adopted. The board voted to approve the reports; one commissioner recorded an abstention while the remaining voting members approved the motion.
Board process and next steps: with the vote to adopt the clinical-registrant notice, staff will file the notice of adoption with the Office of Administrative Law and later publish a notice of application acceptance that explains the application process for clinical registrants. The medical-activity reports approved at the meeting will be sent to the governor’s office and to the legislature as required by statute.
What the rule does and limits: Chief counsel described clinical registrants as a subset of ATCs that, if permitted, will be able to cultivate, manufacture and dispense cannabis products for clinical medical research only when affiliated with a regional academic medical center. The adoption does not change other permit types or adult-use rules; any applicant will still follow the commission’s existing application and vetting procedures.
The commission concluded the item with no further board questions and recorded the passage of both actions. The board moved on to licensing and other agenda items.
